betanal tandem 390 sc
bayer ag - sc (suspensie concentrată) - etofumesat 190 g/l + fenmedifam 200 g/l
pachet tornado extra
adama - etofumesat 200 g/l + desmedifam + fenmedifam 200 g/l + metamitron
etofenamat phagecon 100 mg/g
laboratorios basi-industria farmaceutica, s.a. - portugalia - etofenamatum - gel - 100mg/g - medicamente topice pentru dureri articulare si musculare antiinflamatoare nesteroidiene de uz topic
etomidat-lipuro 2 mg/ml
b. braun melsungen ag - germania - etomidatum - emulsie inj. - 2mg/ml - anestezice generale alte anestezice generale
rheumon 1 g/2 ml
meda manufacturing gmbh - germania - etofenamatum - sol. inj. - 1g/2ml - antiinflamatoare si antireumatice nesteroidiene fenamati
rheumon 100 mg/g
meda manufacturing gmbh - germania - etofenamatum - crema - 100mg/g - medicamente topice pentru dureri articulare si musculare antiinflamatoare nesteroidiene de uz topic
doline 1000 mg/2 ml soluţie injectabilă
abdi ibrahim ilac san. ve tic. a.s. - etofenamatum - soluţie injectabilă - 1000 mg/2 ml
doline 100 mg/ml spray cutanat, soluţie
abdi ibrahim ilac san. ve tic. a.s. - etofenamatum - spray cutanat, soluţie - 100 mg/ml
doline gel 50 mg/g
abdi ibrahim ilac san. ve tic. a.s. - etofenamatum - gel - 50 mg/g
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.